Market Cap

Gamida Cell Ltd. Market Capitalization:

$2.5 Million

USD as of May 1, 2025

business Gamida Cell Ltd. Company Profile

Gamida Cell Ltd. Main Stock Listing

NASDAQ: GMDA

Market Capitalization History of Gamida Cell Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Gamida Cell Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2025 $4.3 M -89.74%
Jan. 1, 2024 $42.3 M -63.66%
Jan. 1, 2023 $116.3 M -53.15%
Jan. 1, 2022 $248.4 M -58.74%
Jan. 1, 2021 $601.9 M 82.17%
Jan. 1, 2020 $330.4 M -68.42%
Jan. 1, 2019 $1.05 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Gamida Cell Ltd. Categories

Israel languages Healthcare languages Biotechnology
Israel Healthcare Israel Biotechnology

Stocks & Indices

Gamida Cell Ltd. has the following listings and related stock indices.


Stock: NASDAQ: GMDA

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.